Three detransitioners shared accounts Thursday alleging that doctors and hospitals encouraged them to pursue gender transition treatments as minors, including medical interventions beginning at ages 12 and 13, according to a Department of Health and Human Services-commissioned report titled "Wolves in White Coats: How Doctors and Hospitals Pushed and Profited from the Fraud of 'Gender Medicine.'"
The HHS report also alleges that financial incentives encouraged hospitals and doctors to provide gender transition treatments and identifies insurance billing practices that may warrant further investigation. The three individuals featured are Clementine Breen, Soren Aldaco and Luke Healy.
Breen testified she was 12 years old when doctors at Children's Hospital Los Angeles told her parents the preteen was "100% trans" and at high risk of suicide without medical intervention, according to the report. She said she began puberty blockers at 12, testosterone at 13 and underwent a double mastectomy at 14. Breen's mental health later deteriorated after therapy led her to conclude that distress surrounding gender identity was connected to earlier trauma from sexual abuse.
What the Right Is Saying
Conservative lawmakers and family advocacy groups praised the HHS report as exposing what they describe as a system that rushed vulnerable young people into irreversible medical interventions. They argue the report demonstrates systemic failures in informed consent and medical ethics.
Vice President JD Vance, who has called on the Department of Justice to prosecute alleged fraud in teen transgender treatment, said the report validates concerns about profit-driven medicine overriding patient welfare. Republican senators have pointed to the report as justification for continued restrictions on federal funding for youth gender procedures.
"This is exactly what parents and advocates have been warning about — a system that treats minors as guinea pigs for experimental treatments," said Sen. Josh Hawley, R-Mo., in floor remarks. "The fact that hospitals may have had financial incentives to push these procedures makes this even more disturbing."
Sen. Marco Rubio, R-Fla., cited the report in calling for congressional hearings: "Congress has a duty to investigate whether federal healthcare programs are being exploited and whether young people are being harmed by a system that prioritizes ideology over medicine."
What the Left Is Saying
Democratic lawmakers and LGBTQ+ advocacy organizations have questioned the timing and political motivations behind the report, noting it comes from an administration that has moved to restrict federal funding for youth gender procedures. They argue that major medical associations including the American Academy of Pediatrics and the American Psychological Association continue to support access to gender-affirming care based on evidence showing mental health benefits for many young people experiencing gender dysphoria.
Critics point out that the report was commissioned by an administration that issued an executive order in January restricting such treatments. They note that detransitioners represent a small percentage of individuals who undergo transition procedures and argue that restricting care based on rare adverse outcomes could harm the far larger number of patients who benefit from these treatments. Some progressive lawmakers have called for more research rather than categorical restrictions.
"We should be very cautious about using individual stories to justify broad policy changes that affect thousands of young people and their families," said Rep. Barbara Lee, D-Calif., in a statement to Politico. "Every medical intervention has risks, but that doesn't mean we ban it — it means we ensure proper informed consent and good clinical practices."
What the Numbers Show
The HHS report does not provide comprehensive statistics on detransition rates. Research on how many individuals regret or reverse gender transition procedures remains limited, with existing studies showing widely varying estimates depending on methodology and definitions used.
A 2021 study published in the journal LGBT Health found that among adults who had undergone gender-affirming surgery, approximately 5% reported some degree of regret, though most described it as limited. The report does not cite this or other peer-reviewed research on regret rates.
The HHS Office of Inspector General has previously identified concerns about improper billing patterns in various federal healthcare programs but has not published specific data on gender medicine billing prior to this report. The new report calls for further investigation into whether certain insurance billing practices related to transition procedures comply with federal requirements.
The Bottom Line
The release of the HHS report marks a significant escalation in the Trump administration's efforts to restrict youth gender treatments, providing what officials describe as documented evidence of systemic problems in how these procedures were recommended and administered. The administration has already moved to limit federal funding for such treatments, and this report is likely to be cited in future regulatory and legislative efforts.
Congressional Republicans have signaled intentions to hold hearings on the findings. Meanwhile, Democratic opponents of the restrictions are expected to challenge the report's methodology and raise concerns about its conclusions being used to justify policies they argue will harm transgender youth who benefit from current standards of care.
Legal challenges to existing funding restrictions are pending in federal courts, where judges may consider both the new HHS report and competing claims from medical associations about the evidence base for gender-affirming care.